Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

CHICAGO, June 25, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a research collaboration with Angiosarcoma Awareness, Inc. to accelerate...

Vadzo Falcon-544CRS is a 5MP USB 3.2 color camera built on the Onsemi AR0544 HyperLux LP sensor, combining Wake-on-Motion ultra-low power standby, enhanced Dynamic Range eDR, and Line Interleaved HDR with a back side illuminated BSI stacked...

Albuquerque, NM, June 30, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the launch of Prostate Macrodissect AI, a clinically validated algorithm designed to automate and...

Tribun Health: A major new milestone in the digital transformation of pathology, benefiting laboratories, clinicians, and patients. Following FDA clearance in 2025, CaloPix's® IVDR certification confirms Tribun Health's ability to serve the...

Partnership grants Bioptimus access to unique European cohort of data Fédération Francophone de Cancérologie Digestive to share high quality clinical data of 3,000 GI cancer patients Significant progress in the STELA programme to...

Ibex Top experts Dr. Ruth March and Dr. Paolo Tarantino named as members, with additional appointments to follow TEL AVIV, Israel – May 5, 2026 – Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today...